Optimizing radiation-responsive gene promoters for radiogenetic cancer therapy

Gene Therapy

Volumn 9, Issue 20, 2002, Pages 1396-1402

  Scott, S D ^a,b   Joiner, M C ^a,b   Marples, B ^a,b  

^a Gray Cancer Institute   (United Kingdom)

^b KARMANOS CANCER INSTITUTE   (United States)

Author keywords

CArG elements; GDEPT; Promoters; Radiation; SRF

Indexed keywords

ADENINE; DNA; EARLY GROWTH RESPONSE FACTOR 1; GANCICLOVIR; PLASMID VECTOR; THYMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; BREAST ADENOCARCINOMA; CONSENSUS SEQUENCE; CONTROLLED STUDY; DNA FLANKING REGION; DNA SEQUENCE; DRUG EFFICACY; ENHANCER REGION; FEMALE; GENE CONSTRUCT; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE SWITCHING; GENE TARGETING; GENETIC TRANSFECTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IONIZING RADIATION; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN MOTIF; RADIATION DOSE; RADIATION RESPONSE; REPORTER GENE; SUICIDE GENE THERAPY; TUMOR CELL LINE;

ADENOCARCINOMA; ANIMALS; BREAST NEOPLASMS; ENHANCER ELEMENTS (GENETICS); ENZYME PRECURSORS; FEMALE; GENE EXPRESSION; GENE THERAPY; GENETIC ENGINEERING; GENETIC VECTORS; GLIOBLASTOMA; HUMANS; MICE; MICE, NUDE; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; PROMOTER REGIONS (GENETICS); RADIOTHERAPY; TRANSFECTION; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0036773207     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301822     Document Type: Article

References (33)

1. Datta R et al. Ionizing radiation activates transcription of the EGR1 gene via CArG elements. Proc Natl Acad Sci USA 1992; 89: 10149-10153.
2. Weichselbaum RR et al. Gene therapy targeted by radiation preferentially radiosensitizes tumor cells. Cancer Res 1994; 54: 4266-4269.
3. Joki T, Nakamura M, Ohno T. Activation of the radiosensitive EGR-1 promoter induces expression of the herpes simplex virus thymidine kinase gene and sensitivity of human glioma cells to ganciclovir. Hum Gene Ther 1995; 6: 1507-1513.
4. Worthington J et al. Modification of vascular tone using iNOS under the control of a radiation-inducible promoter. Gene Therapy 2000; 7: 1126-1131.
5. Nuyts S et al. Radio-responsive recA promoter significantly increases TNFalpha production in recombinant clostridia after 2 Gy irradiation. Gene Therapy 2001; 8: 1197-1201.
6. Marples B et al. Development of synthetic promoters for radiation-mediated gene therapy. Gene Therapy 2000; 7: 511-517.
7. Treisman R. The SRE: a growth factor responsive transcriptional regulator. Semin Cancer Biol 1990; 1: 47-58.
8. Christy B, Nathans D. Functional serum response elements upstream of the growth factor-inducible gene zif268. Mol Cell Biol 1989; 9: 4889-4895.
9. Shaw PE, Schroter H, Nordheim A. The ability of a ternary complex to form over the serum response element correlates with serum inducibility of the human c-fos promoter. Cell 1989; 56:563-572.
10. Dalton S, Treisman R. Characterization of SAP-1, a protein recruited by serum response factor to the c-fos serum response element. Cell 1992; 68: 597-612.
11. Hill CS et al. Functional analysis of a growth factor-responsive transcription factor complex. Cell 1993; 73: 395-406.
12. Lim CP, Jain N, Cao X. Stress-induced immediate-early gene, egr-1, involves activation of p38/JNK1. Oncogene 1998; 16:2915-2926.
13. Meyer RG, Kupper JH, Kandolf R, Rodemann HP. Early growth response-1 gene (Egr-1) promoter induction by ionizing radiation in U87 malignant glioma cells in vitro. Eur J Biochem 2002; 269: 337-346.
14. Hallahan DE et al. Spatial and temporal control of gene therapy using ionizing radiation. Nat Med 1995; 1: 786-791.
15. Seung LP et al. Genetic radiotherapy overcomes tumor resistance to cytotoxic agents. Cancer Res 1995; 55: 5561-5565.
16. Staba MJ et al. Adenoviral TNF-alpha gene therapy and radiation damage tumor vasculature in a human malignant glioma xenograft. Gene Therapy 1998; 5: 293-300.
17. Kawashita Y et al. Regression of hepatocellular carcinoma in vitro and in vivo by radiosensitizing suicide gene therapy under the inducible and spatial control of radiation. Hum Gene Ther 1999; 10: 1509-1519.
18. Sakamoto KM. 5′ upstream sequence and genomic structure of the human primary response gene, EGR-1/TIS8. Oncogene 1991; 6: 867-871.
19. Spencer JA, Misra RP. Expression of the serum response factor gene is regulated by serum response factor binding sites. J Biol Chem 1996; 271: 16535-16543.
20. Schwachtgen JL, Campbell CJ, Braddock M. Full promoter sequence of human early growth response factor-1 (Egr-1): demonstration of a fifth functional serum response element. DNA Seq 2000; 10: 429-432.
21. Prywes R, Roeder RG. Purification of the c-fos enhancer-binding protein. Mol Cell Biol 1987; 7: 3482-3489.
22. Spencer JA, Misra RP. Expression of the SRF gene occurs through a Ras/Sp/SRF-mediated- mechanism in response to serum growth signals. Oncogene 1999; 18: 7319-7327.
23. Kokoris MS, Sabo P, Adman ET, Black ME. Enhancement of tumor ablation by a selected HSV-1 thymidine kinase mutant. Gene Therapy 1999; 6: 1415-1426.
24. Datta R et al. Reactive oxygen intermediates target CC(A/T)6GG sequences to mediate activation of the early growth response 1 transcription factor gene by ionizing radiation. Proc Natl Acad Sci USA 1993; 90: 2419-2422.
25. Treisman R. Identification of a protein-binding site that mediates transcriptional response of the c-fos gene to serum factors. Cell 1986; 46: 567-574.
26. Pellegrini L, Tan S, Richmond TJ. Structure of serum response factor core bound to DNA. Nature 1995; 376: 490-498.
27. Ruan H et al. A hypoxia-regulated adeno-associated virus vector for cancer-specific gene therapy. Neoplasia 2001; 3: 255-263.
28. Shibata T et al. Enhancement of gene expression under hypoxic conditions using fragments of the human vascular endothelial growth factor and the erythropoietin genes. Int J Radiat Oncol Biol Phys 1998; 42: 913-916.
29. Greco O et al. Novel chimeric gene promoters responsive to hypoxia and ionizing radiation. Gene Therapy 2002 (in press).
30. Pollock R, Treisman R. A sensitive method for the determination of protein-DNA binding specificities. Nucleic Acids Res 1990; 18: 6197-6204.
31. Treisman R, Marais R, Wynne J. Spatial flexibility in ternary complexes between SRF and its accessory proteins. EMBO J 1992; 11: 4631-4640.
32. Scott SD et al. A radiation-controlled molecular switch for use in gene therapy of cancer. Gene Therapy 2000; 7: 1121-1125.
33. Kjellen E et al. A therapeutic benefit from combining normobaric carbogen or oxygen with nicotinamide in fractionated X-ray treatments. Radiother Oncol 1991; 22: 81-91.